LVW Advisors’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,247
| Closed | -$489K | – | 330 |
|
|
2025
Q1 | $489K | Buy |
3,247
+189
| +6% | +$28.4K | 0.06% | 172 |
|
|
2024
Q4 | $565K | Sell |
3,058
-410
| -12% | -$75.7K | 0.07% | 169 |
|
|
2024
Q3 | $683K | Buy |
3,468
+363
| +12% | +$71.5K | 0.09% | 149 |
|
|
2024
Q2 | $641K | Buy |
3,105
+269
| +9% | +$55.6K | 0.09% | 135 |
|
|
2024
Q1 | $768K | Sell |
2,836
-61
| -2% | -$16.5K | 0.13% | 121 |
|
|
2023
Q4 | $685K | Sell |
2,897
-48
| -2% | -$11.3K | 0.13% | 117 |
|
|
2023
Q3 | $577K | Sell |
2,945
-264
| -8% | -$51.7K | 0.12% | 112 |
|
|
2023
Q2 | $675K | Sell |
3,209
-33
| -1% | -$6.94K | 0.13% | 104 |
|
|
2023
Q1 | $654K | Sell |
3,242
-95
| -3% | -$19.2K | 0.13% | 117 |
|
|
2022
Q4 | $727K | Sell |
3,337
-252
| -7% | -$54.9K | 0.15% | 107 |
|
|
2022
Q3 | $706K | Buy |
3,589
+91
| +3% | +$17.9K | 0.16% | 99 |
|
|
2022
Q2 | $748K | Buy |
3,498
+182
| +5% | +$38.9K | 0.15% | 97 |
|
|
2022
Q1 | $942K | Sell |
3,316
-179
| -5% | -$50.9K | 0.16% | 89 |
|
|
2021
Q4 | $1.32M | Sell |
3,495
-59
| -2% | -$22.2K | 0.22% | 78 |
|
|
2021
Q3 | $1.47M | Buy |
3,554
+42
| +1% | +$17.3K | 0.25% | 70 |
|
|
2021
Q2 | $1.3M | Sell |
3,512
-372
| -10% | -$138K | 0.23% | 72 |
|
|
2021
Q1 | $1.13M | Buy |
3,884
+1,101
| +40% | +$319K | 0.22% | 74 |
|
|
2020
Q4 | $695K | Buy |
2,783
+105
| +4% | +$26.2K | 0.14% | 91 |
|
|
2020
Q3 | $606K | Buy |
2,678
+850
| +46% | +$192K | 0.13% | 94 |
|
|
2020
Q2 | $319K | Buy |
+1,828
| New | +$319K | 0.08% | 140 |
|